SCHEMBL7990050

SCHEMBL7990050

CC(C)OP(=O)(OC(C)C)C(CSCC(=O)O)P(=O)(OC(C)C)OC(C)C

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.38
HIF1A Q16665 1/20 0.38
HMGCR P04035 10/20 0.35
POLB P06746 2/20 0.35
MVD P53602 1/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 1/20 0.33
TRPA1 O75762 1/20 0.33
KMT2A Q03164 1/20 0.33
GMNN O75496 1/20 0.32
TP53 P04637 1/20 0.32
THRB P10828 1/20 0.32
CYP2C9 P11712 1/20 0.32
BLM P54132 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CTSA P10619 1/20 0.30
ACHE P22303 1/20 0.30
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989596 0.81 CYP2D6 (0.41) CYP2D6HIF1APOLBMVDMAPT
SCHEMBL7882568 0.79 CYP2D6 (0.38) CYP2D6HIF1AHMGCRPOLBMVD
SCHEMBL7998419 0.76 MVD (0.38) CYP2D6HIF1AHMGCRPOLBMVD
SCHEMBL6016751 0.75 HMGCR (0.39) HMGCRPOLBCTSAACHEKDM4E
SCHEMBL8002512 0.73 GMNN (0.42) CYP2D6HIF1APOLBMVDMAPT
SCHEMBL5324634 0.72 GABRP (0.43) HMGCRPOLB
SCHEMBL5327876 0.70 FOLH1 (0.42) HMGCRPOLBCTSAACHE
SCHEMBL2203031 0.69
SCHEMBL8385734 0.69 ALDH1A1 (0.44) MEN1KMT2AHSD17B10
SCHEMBL4271792 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0944635-A4 DIPHOSPHONATE THERAPEUTIC COMPOUNDS ELIZANOR BIOPHARMACEUTICALS IN (US) 2000-07-05 EP claimed
EP-0944635-A1 DIPHOSPHONATE THERAPEUTIC COMPOUNDS Elizanor Biopharmaceuticals, Inc. (US) 1999-09-29 EP claimed
WO-1998015560-A1 DIPHOSPHONATE THERAPEUTIC COMPOUNDS ELIZANOR BIOPHARMACEUTICALS, INC. (US) 1998-04-16 WO claimed